Cystic fibrosis
MONDO:0009061Autosomal recessive disorder caused by pathogenic variants in the CFTR gene (cystic fibrosis transmembrane conductance regulator), which encodes a chloride and bicarbonate channel expressed in epithelial cells, and follow the diagnosis criteria. Diagnosis requires evidence of CFTR dysfunction, defined as a sweat chloride concentration of 60 mmol/L or greater, or identification of two CF-causing CFTR pathogenic variants, or an abnormal nasal potential difference measurement. CF is a progressive, multi-organ disease characterized by chronic obstructive lung disease with recurrent infections, exocrine pancreatic insufficiency, intestinal obstruction (including meconium ileus in neonates), male infertility due to obstructive azoospermia, hepatobiliary complications, and elevated sweat chloride concentrations.
Also known as: CF, cystic fibrosis, cystic fibrosis lung disease, modifier of, mucoviscidosis, pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis, fibrocystic disease of the pancreas
261 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Could a special supplement boost health in cystic fibrosis?
Disease control Not yet recruitingThis study will test whether a nutrition supplement with different forms of certain nutrients works better than standard supplements for adults with cystic fibrosis. Sixty participants will take the supplement for six weeks, and researchers will measure nutrient levels in their b…
Phase: NA • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New enzyme could help digest food for those with pancreatic problems
Disease control Not yet recruitingThis study tests a new lab-made enzyme called NHS7108 in people with exocrine pancreatic insufficiency (EPI), a condition where the pancreas doesn't make enough enzymes to digest food. About 66 adults will take either NHS7108 or the standard enzyme Zenpep for 14 days each, while …
Phase: PHASE2 • Sponsor: Aimmune Nestlé Health Science US R&D, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Virus cocktail targets tough lung bugs in cystic fibrosis trial
Disease control Not yet recruitingThis early-stage trial tests a new treatment called AchromoPhage, a mix of four viruses that specifically kill Achromobacter bacteria, in 12 adults with cystic fibrosis and chronic lung infections. Participants will receive the treatment by inhalation, IV, or both over three week…
Phase: PHASE1 • Sponsor: Ghady Haidar • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New inhaled mRNA therapy aims to fix cystic fibrosis at its source
Disease control Not yet recruitingThis early-phase study tests an inhaled mRNA drug (BMD003) in 24 people aged 12 and older with cystic fibrosis. The goal is to see if it is safe and can improve lung function by delivering instructions to make a working CFTR protein. Participants will receive multiple doses and b…
Phase: EARLY_PHASE1 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Breast cancer drug tamoxifen tested as new hope for cystic fibrosis
Disease control Not yet recruitingThis study tests whether tamoxifen citrate, a drug commonly used for breast cancer, is safe and tolerable for adults with cystic fibrosis who cannot take current CFTR modulator drugs. Thirty-five participants will take one tablet daily for six months and visit the clinic every 28…
Phase: PHASE2 • Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Virus cocktail takes on superbugs in cystic fibrosis trial
Disease control Not yet recruitingThis early-stage study tests whether adding specially-made viruses (phages) to standard antibiotics can safely treat stubborn lung infections in adults with cystic fibrosis. About 30 participants will receive a 7-day course of both treatments. The main goal is to check safety, bu…
Phase: PHASE1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New sweat patch could make cystic fibrosis testing easier
Diagnosis Not yet recruitingThis study will test a new device called the micro Sweat Test Patch (µSTP) that measures chloride levels in sweat to help diagnose and monitor cystic fibrosis (CF). Researchers will compare the new patch to the standard sweat test in 300 newborns, children, and adults with CF. Th…
Phase: NA • Sponsor: Emory University • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Mini organs could solve cystic fibrosis diagnosis puzzle
Diagnosis Not yet recruitingThis study aims to develop a more accurate test for cystic fibrosis (CF) using lab-grown mini organs called organoids, made from a small piece of gut tissue. The researchers will compare this new test with current methods like sweat tests and genetic testing in 80 people who are …
Sponsor: Royal Brompton & Harefield NHS Foundation Trust • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Could a simple saltwater mist make breathing easier for lung patients?
Symptom relief Not yet recruitingThis study looks at whether adding a continuous saltwater mist to warm, humidified air can make thick lung mucus easier to clear. 35 adults hospitalized with lung conditions like COPD or cystic fibrosis will receive both treatments on separate days. Researchers will measure mucus…
Phase: NA • Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy aims to clear lungs and boost stamina in cystic fibrosis
Symptom relief Not yet recruitingThis study tests whether adding exercise training to a standard chest-vibration vest (HFCWO) helps people with cystic fibrosis clear mucus, cough less, and walk farther. Twenty-four adults aged 16–35 will either get the vest plus exercise or the vest alone for 8 weeks. The goal i…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Cartoons and stories soothe Kids' fear during breathing treatments
Symptom relief Not yet recruitingThis study looks at whether watching cartoons or listening to breath-synchronized interactive stories can help children aged 6-9 feel less afraid and more comfortable while using a nebulizer for breathing medication. About 96 children with respiratory conditions will be randomly …
Phase: NA • Sponsor: Mersin University • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Remote rehab: a new hope for cystic fibrosis patients battling frailty
Symptom relief Not yet recruitingThis study tests whether an 8-week tele-rehabilitation program can improve muscle mass, reduce frailty, and enhance quality of life in adults with cystic fibrosis. Participants will do supervised exercise sessions at home via video calls three times a week. The goal is to see if …
Phase: NA • Sponsor: King Saud University • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Cold therapy could take the ouch out of blood tests
Symptom relief Not yet recruitingThis study tests if applying cold (cryotherapy) to the wrist before a blood draw from the artery can reduce pain. It involves 258 adults with chronic respiratory diseases who need this test. The goal is to find a simple, drug-free way to make the procedure less painful.
Phase: PHASE3 • Sponsor: University Hospital, Brest • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Air pollution may worsen cystic fibrosis in kids, study hopes to find out
Knowledge-focused Not yet recruitingThis study will enroll 200 children with cystic fibrosis (100 Hispanic, 100 non-Hispanic white) to measure indoor and outdoor air pollution and see how it relates to lung function, inflammation, and airway bacteria. Researchers hope to understand why Hispanic children often have …
Sponsor: Seattle Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Scientists track hidden threat of antibiotic resistance in lung patients
Knowledge-focused Not yet recruitingThis study follows people with chronic lung diseases like bronchiectasis, cystic fibrosis, and COPD to understand how bacteria become resistant to antibiotics. Researchers will collect samples and health data over time to map resistance patterns and genetic causes. The goal is to…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
How strong should you be? new study aims to find out
Knowledge-focused Not yet recruitingThis study will measure leg and handgrip strength in about 2,800 healthy adults and people with chronic lung diseases across Spain, Portugal, and Italy. Researchers want to create normal muscle strength values for these populations and see if the same standards can apply to peopl…
Sponsor: University of Alcala • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
New MRI method could track cystic fibrosis lung damage without X-Rays
Knowledge-focused Not yet recruitingThis study explores whether MRI can produce clear images of the lungs and airways in people with cystic fibrosis (CF) and healthy volunteers. Researchers will use computer assistance to measure airway size and shape, and repeat the MRI two years later to see if changes occur. A s…
Sponsor: The Hospital for Sick Children • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New european registry aims to unlock mysteries of rare breast disease
Knowledge-focused Not yet recruitingThis study is creating a European registry for people with idiopathic granulomatous mastitis (IGM), a rare inflammatory breast condition that causes pain, redness, and abscesses. Researchers will collect information from 1,000 participants to better understand symptoms, treatment…
Sponsor: European Breast Cancer Research Association of Surgical Trialists • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
New study to track cystic fibrosis drugs in pregnancy and breast milk
Knowledge-focused Not yet recruitingThis study looks at how cystic fibrosis medications (CFTR modulators) change in the body during pregnancy and after childbirth in 30 women. Researchers will measure drug levels in blood, breast milk, and umbilical cord blood. The goal is to understand how these drugs work in preg…
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC